Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Shimadzu Scientific Instruments Introduces Noviplex Cards

Published: Wednesday, April 23, 2014
Last Updated: Wednesday, April 23, 2014
Bookmark and Share
Noviplex™ Next Generation Plasma Sample Collection tool for accelerated blood plasma collection and disease analysis.

Shimadzu Scientific Instruments (SSI) has introduced the Noviplex™ Next Generation Plasma Sample Collection tool. Noviplex Cards allow for rapid collection of a volumetric sample of plasma from an unmeasured amount of whole blood within minutes. The technology is ideal for use with LC-MS/MS analysis.

Noviplex Cards offer significant advantages for laboratory and medical professionals, accelerating analysis and simplifying blood collection by eliminating the need for phlebotomy, syringes and glass collection tubes.

“Noviplex technology enables lab-free sample preparation, and the convenient ‘lab-on-a-card’ format rapidly generates plasma for LC-MS/MS analysis,” said Scott Kuzdzal, PhD, life science business unit manager at SSI. “This will greatly simplify collection and processing in medical clinics, labs and hospitals.”

Shimadzu partnered with Novilytic Laboratories to offer Noviplex Cards. The technology allows plasma generation from a finger-stick as opposed to traditional methods of blood collection and preparation.

Plasma can be generated from specimen volumes ranging from 20 to 75 µL of whole blood. The technology offers a single-step, solid-phase method for sample preparation and analyte extraction. Noviplex accelerates processes by eliminating refrigeration, centrifugation solvent extraction and evaporation.

“Next-generation Novilytic Laboratory advances in sample collection and preparation vastly accelerate disease marker analysis and enable a paradigm change in clinical chemistry, wellness monitoring and medicine,” said Fred Regnier, PhD, Professor Emeritus, John H. Law Distinguished Professor of Chemistry, Purdue University, and a co-founder of Novilytic Laboratories.

Noviplex also provides exceptional reproducibility independent of hematocrit, 99 percent removal of red blood cells, and rapid sample preparation for MS-based analysis while maintaining assay reproducibility and selectivity.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Key Piece of MRSA Vaccine Puzzle
New research funded by the Health Research Board and the Wellcome Trust has pinpointed immune cells that could be targeted by an MRSA vaccine.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos